Contents Vial: Pentadecapeptide BPC - 157: 5mg.
Ampoule: 2ml Sterile water for injection.
Administration Intramuscular or Subcutaneous injection.
Description SPIERECTOR also known as BPC 157 ( Body Protecting Compound) is a 15 amino acid peptidergic growth factor produced in GI tract. Originally anti-ulcer stable gastric pentadecapeptide BPC 157 has shown to promote healing of injured striated muscle and smooth muscle. SPIERECTOR has been shown to benefit ulcers in the stomach, intestinal damage such as fistulas and inflammatory disorders, wound and fracture (pseudoarthrosis) healing, bone and joint healing, and organ damage. It also has neuroprotective influences on brain cells. Researchers have observed marked protective effects when SPIERECTOR is administered to rats alongside a research toxin or damaging surgical procedure.
Storage Store at room temperature away from heat and direct sunlight pre reconstitution. Refrigerate between 2-8’C post Reconstitution.
Dosage Initial: 2mcg/kg/day. May increase dose gradually. Max: 400 mcg/day.
Indication SPIERECTOR can be prescribed in case of pancreas damage, liver injuries, endothelium and heart damage, i.e. dysrhythmias following reoxygenation, and blood pressure, along with effect on experimental acute/chronic inflammation, wound and fracture (pseudoarthrosis) healing. SPIERECTOR is also effective in the treatment of IBS (irritable bowel syndrome).
Contraindications Acute critical illness due to heart, multiple accidental trauma or respiratory failure; active neoplasms, proliferative or pre-proliferative diabetic retinopathy; lactation; patients with closed epiphyses. Intracranial lesions. Patients with Prader-Willi syndrome who are severely obese or have a severe respiratory impairment.
Special Precautions DM; may require dose reduction in insulin. Pregnancy. Discontinue treatment if there is evidence of tumor growth. Monitoring in patients with scoliosis is recommended due to a risk of progression of scoliosis.
Adverse Drug Reactions No side effects found yet in clinical trials.